Locally Advanced Malignant Solid Neoplasm clinical trials at UC Irvine
1 research study open to eligible people
open to eligible people ages 18 years and up
This phase II trial studies how well adavosertib works in treating patients with SETD2-deficient solid tumors that have spread to other places in the body (advanced/metastatic). Adavosertib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Orange, California and other locations